Federal Register / Vol. 83, No. 136 / Monday, July 16, 2018 / Notices 32905 

1The record is defined in sec. 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2Citric Acid and Certain Citrate Salts from 

Thailand: Affirmative Final Determination of Sales 

at Less Than Fair Value and Final Affirmative 

Determination of Critical Circumstances in Part, 82 

FR 25998, June 5, 2018; Citric Acid and Certain 

Citrate Salts from Belgium: Affirmative Final 

Determination of Sales at Less Than Fair Value, 82 

FR 26001, June 5, 2018; Citric Acid and Certain 

Citrate Salts from Colombia: Affirmative Final 

Determination of Sales at Less Than Fair Value and 

Final Negative Determination of Critical 

Circumstances, 82 FR 26002, June 5, 2018. 

3The Commission also finds that imports subject 

to Commerce’s affirmative critical circumstances 

determination are not likely to undermine seriously 

the remedial effect of the antidumping duty order 

on Thailand. 

4Commissioner Jason E. Kearns did not 

participate in these investigations. 

Transboundary Hydrocarbon Reservoirs 

in the Gulf of Mexico. These eight 

stipulations will be added as lease terms 

where applicable and will be 

enforceable as part of the lease. 

Appendix B of the Gulf of Mexico OCS 

Oil and Gas Lease Sales: 2017–2022; 

Gulf of Mexico Lease Sales 249, 250, 

251, 252, 253, 254, 256, 257, 259, and 

261; Final Multisale Environmental 

Impact Statement provides a list and 

description of standard post-lease 

conditions of approval that may be 

required by BOEM or the Bureau of 

Safety and Environmental Enforcement 

as a result of plan and permit review 

processes for the Gulf of Mexico OCS 

Region. 

After careful consideration, BOEM 

has selected the preferred alternative 

(Alternative A) in the 2018 GOM 

Supplemental EIS for proposed Lease 

Sale 251. BOEM’s selection of the 

preferred alternative meets the purpose 

and need for the proposed action, as 

identified in the 2018 GOM 

Supplemental EIS, and provides for 

orderly resource development with 

protection of the human, marine, and 

coastal environments while also 

ensuring that the public receives an 

equitable return for these resources and 

that free-market competition is 

maintained. 

Authority: This Notice of Availability of a 

Record of Decision is published pursuant to 

the regulations (40 CFR part 1505) 

implementing the provisions of the National 

Environmental Policy Act of 1969, as 

amended (42 U.S.C. 4321 et seq.). 

Dated: July 11, 2018. 

Walter D. Cruickshank, 

Acting Director, Bureau of Ocean Energy 

Management. 

[FR Doc. 2018–15181 Filed 7–13–18; 8:45 am] 

BILLING CODE 4310–MR–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1374–1376 

(Final)] 

Citric Acid and Certain Citrate Salts 

From Belgium, Colombia, and Thailand 

Determination 

On the basis of the record 1 developed 

in the subject investigations, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

materially injured by reason of imports 

of citric acid and certain citrate salts 

from Belgium, Colombia, and Thailand 

that have been found by the U.S. 

Department of Commerce (‘‘Commerce’’) 

to be sold in the United States at less 

than fair value (‘‘LTFV’’).234

Background 

The Commission, pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)), 

instituted these investigations effective 

June 2, 2017, following receipt of a 

petition filed with the Commission and 

Commerce by Archer Daniels Midland 

Company, Decatur, Illinois; Cargill, 

Incorporated, Minneapolis, Minnesota; 

and Tate & Lyle Ingredients Americas, 

LLC, Hoffman Estates, Illinois. The 

Commission scheduled the final phase 

of the investigations following 

notification of a preliminary 

determination by Commerce that 

imports of citric acid and certain citrate 

salts from Belgium, Colombia, and 

Thailand were being sold at LTFV 

within the meaning of section 733(b) of 

the Act (19 U.S.C. 1673b(b)). Notice of 

the scheduling of the final phase of the 

Commission’s investigation and of a 

public hearing to be held in connection 

therewith was given by posting copies 

of the notice in the Office of the 

Secretary, U.S. International Trade 

Commission, Washington, DC, and by 

publishing the notice in the Federal 

Register of February 2, 2018 (83 FR 

4922). The hearing was held in 

Washington, DC, on May 14, 2018, and 

all persons who requested the 

opportunity were permitted to appear in 

person or by counsel. 

The Commission made these 

determinations pursuant to section 

735(b) of the Act (19 U.S.C. 1673d(b)). 

It completed and filed its 

determinations in these investigations 

on July 10, 2018. The views of the 

Commission are contained in USITC 

Publication 4799 (July 2018), entitled 

Citric Acid and Certain Citrate Salts 

from Belgium, Colombia, and Thailand: 

Investigation Nos. 731–TA–1374–1376 

(Final). 

By order of the Commission. 

Issued: July 10, 2018. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2018–15067 Filed 7–13–18; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Siegfried 

USA, LLC 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 14, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on 

November 2, 2017, Siegfried USA, LLC, 

33 Industrial Park Rd., Pennsville, NJ 

08070 applied to be registered as a bulk 

manufacturer for the basic classes of 

controlled substances: 

Controlled 

substance Drug code Schedule 

Gamma Hydroxybutyric Acid.2010 I 

Dihydromorphine .... 9145 I 

Hydromorphinol ...... 9301 I 


sradovich on DSK3GMQ082PROD with NOTICES